SCR-LIP-000585 · Claim · machine-readable JSON →

Limited evidence suggests lipedema may be accompanied by lower rates of metabolic comorbidity than in women of similar age in the general population.

General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

2018Lipedema: friend and foe — Torre et al. (2018) · consistent

Evidence (1)

Context (PECO)

Populationwomen with lipedema, mean BMI 35.3 kg/m²
Conditionlipedema
Exposurepresence of lipedema fat
Comparatorexpected rates for general obesity population
Outcomemetabolic dysfunction prevalence (diabetes, dyslipidemia, hypertension)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log